Brendon Neuen's Publications

About Brendon Neuen's Publications

Program Lead, Renal and Metabolic
  • Nephrologist and Director, Kidney Trials, Royal North Shore Hospital
  • Clinical Associate Professor, University of Sydney
  • Conjoint Associate Professor, UNSW Sydney
  • Ph.D. ,
  • MBBS(Hons),
  • MSc(Oxon),
  • FRACP,
  • FASN

  • From progression to remission: a new paradigm for success in chronic kidney disease

    Kidney International Date published:

  • Randomized trials in cardiovascular, kidney, and metabolic diseases: rethinking late-phase drug development

    European Heart Journal Date published:

  • Patterns of follow-up testing of abnormal eGFR and UACR for the detection of chronic kidney disease in Australian primary care: analysis of a national general practice dataset

    BMJ Open Date published:

  • Predictive Value of Established and Novel Biomarkers for Kidney Outcomes in CKD: A Comparative Validation Study

    Journal of the American Society of Nephrology Date published:

  • Variability in eGFR and Adverse Kidney Outcomes in Routine Clinical Practice

    Journal of the American Society of Nephrology Date published:

  • Incidence of CKD in Australian Primary Care: Analysis of a National Primary Care Dataset

    Journal of the American Society of Nephrology Date published:

  • Effects of Therapies on Proteinuria and Estimated Glomerular Filtration Rate in IgA Nephropathy: Meta-Analysis of Randomized Trials

    Clinical Journal of the American Society of Nephrology Date published:

  • Glomerular filtration rate slope in heart failure: ready for prime time?

    European Heart Journal Date published:

  • Decline in glomerular filtration rate as an endpoint in heart failure clinical trials: challenges and solutions

    European Heart Journal Date published:

  • Quality of care for people with chronic kidney disease: a systematic review and meta-analysis

    BMJ Open Date published:

  • Changing paradigms of studies in kidney diseases

    Kidney International Date published:

  • Cardiovascular, kidney, and metabolic health: an actionable vision for heart failure prevention

    The Lancet Date published:

  • Natriuretic Peptides, Body Mass Index, and Clinical Outcomes in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

    JACC Date published:

  • Obesity and Risk of Kidney Outcomes in Heart Failure With Preserved Ejection Fraction

    JACC: Heart Failure Date published:

  • Combining SGLT2i and MRAs in Heart Failure

    Journal of the American College of Cardiology Date published:

  • Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care dataset

    Diabetes, Obesity and Metabolism Date published: